Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Proteins Involved in Myocardial Ischemia	6/252	2.131366239233949E-6	9.740343713299147E-4	0	0	19.241951219512195	251.27577963130534	KMT2A;PRKCB;PRKCD;ARRB1;STK4;JAK2
FLT3/KIT/MLL Signaling in Leukemia	3/29	1.1987759419957194E-5	0.002739203027460219	0	0	82.1826923076923	931.263407749183	KMT2A;KAT6A;JAK2
Peripheral Tissue Microangiopathy	3/46	4.892130248246828E-5	0.005467976697926241	0	0	49.64950166112957	492.78608080822454	PRKCB;PRKCD;EP300
Proteins Involved in Prostate Cancer	4/138	5.907580385412161E-5	0.005467976697926241	0	0	21.929242675511333	213.5182187359257	CDH1;VDR;EP300;JAK2
Acetylases Inhibition in Histone Deacetylation in Cancer	2/9	8.313599120396748E-5	0.005467976697926241	0	0	196.66995073891624	1847.7206463680611	KAT6A;EP300
Kruppel-like Factor 6 Signaling in Prostate Cancer	2/9	8.313599120396748E-5	0.005467976697926241	0	0	196.66995073891624	1847.7206463680611	CDH1;EP300
Hepatic Stellate Cells in non-Alcoholic Fatty Liver Disease	3/55	8.375456648902339E-5	0.005467976697926241	0	0	41.03777472527472	385.2470291649699	CDH1;EP300;JAK2
IFNG -> ARRB1/STAT1 Signaling	2/10	1.0381978350160118E-4	0.0059307051325289675	0	0	172.07758620689654	1578.4425771666922	ARRB1;JAK2
Proteins Involved in Diabetic Neuropathy	3/65	1.379928839542096E-4	0.0063062747967073795	0	0	34.401497695852534	305.7711223078785	VDR;PRKCB;PRKCD
Clear Cell Endometrial Cancer and Papillary Serous Endometrial Cancer	3/65	1.379928839542096E-4	0.0063062747967073795	0	0	34.401497695852534	305.7711223078785	CDH1;EP300;JAK2
Genes with Mutations in Cancer-Associated Histone Deacetylation	2/13	1.7943408999380463E-4	0.007166549674610572	0	0	125.12852664576802	1079.3214581392901	KAT6A;EP300
Protein Kinase C in Diabetic Microangiopathy	2/14	2.0913783305828018E-4	0.007166549674610572	0	0	114.69540229885058	971.7587498188318	PRKCB;PRKCD
CXC Chemokine Receptor Signaling	3/75	2.1109909982283402E-4	0.007166549674610572	0	0	29.608630952380953	250.58325820160184	PRKCB;PRKCD;JAK2
Mast-Cell Activation in Asthma	3/76	2.1954419134474396E-4	0.007166549674610572	0	0	29.201565557729943	245.9927331283584	PRKCB;PRKCD;JAK2
IL13/STAT6/ZEB1 Signalling Promotes Cancer Metastatic Progression	2/15	2.4108009623731251E-4	0.007344906932030121	0	0	105.86737400530504	881.9155958865495	CDH1;JAK2
Acute Myeloid Leukemia	3/82	2.748359360217822E-4	0.007399483773073502	0	0	26.975587703435806	221.18191370685673	KMT2A;KAT6A;JAK2
CDC73 Mutations Cause Hyperparathyroidism	2/16	2.75254319786104E-4	0.007399483773073502	0	0	98.30049261083744	805.8492615260942	KMT2A;CTR9
Mast-Cell Activation via IgE Signaling	3/86	3.1627225677617713E-4	0.008003726115123273	0	0	25.67039586919105	206.87533664004872	PRKCB;PRKCD;JAK2
CC Chemokine Receptor Signaling	3/88	3.38419029096839E-4	0.008003726115123273	0	0	25.063865546218487	200.29100647567643	PRKCB;PRKCD;JAK2
CR3 Mediated Phagocytosis in Neutrophils and Macrophages	2/18	3.5027247768592E-4	0.008003726115123273	0	0	86.00431034482759	684.3190276353239	PRKCB;PRKCD
Proteins Involved in Colorectal Neoplasms	3/99	4.781709116554196E-4	0.010405909839358417	0	0	22.1796875	169.57573972762742	CDH1;VDR;PRKCB
Proteins Involved in Obesity	3/106	5.83841527304732E-4	0.011600677303402718	0	0	20.66504854368932	153.86949168142752	VDR;PRKCD;EP300
Endometrial Cancer	3/106	5.83841527304732E-4	0.011600677303402718	0	0	20.66504854368932	153.86949168142752	CDH1;EP300;JAK2
Proteins Involved in Arterial Hypertension	4/255	6.194064972132256E-4	0.01179453205110184	0	0	11.638187988785598	85.968371171426	VDR;PRKCB;PRKCD;JAK2
Tertiary Hypothyroidism	2/28	8.570688316410276E-4	0.014009606448431236	0	0	52.89920424403183	373.5737744029888	PRKCB;JAK2
Histone Methylation	2/28	8.570688316410276E-4	0.014009606448431236	0	0	52.89920424403183	373.5737744029888	KDM3A;GFI1B
Central Hypothyroidism	2/28	8.570688316410276E-4	0.014009606448431236	0	0	52.89920424403183	373.5737744029888	PRKCB;JAK2
Prostate Cancer	3/123	8.996796055151054E-4	0.014009606448431236	0	0	17.72232142857143	124.29500248948462	VDR;EP300;JAK2
Eat me Signal: Apoptotic Cell Induces Phagocytosis	2/29	9.196678193718536E-4	0.014009606448431236	0	0	50.93742017879949	356.128872274134	PRKCB;PRKCD
IL6 Promotes Inflammation in Muscular Dystrophies	2/29	9.196678193718536E-4	0.014009606448431236	0	0	50.93742017879949	356.128872274134	PRKCD;JAK2
Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway	2/31	0.0010512841071621476	0.014191770784633287	0	0	47.41973840665874	325.1923745116612	CDH1;EP300
Vitamine D Deficite and Dentin Formation	2/31	0.0010512841071621476	0.014191770784633287	0	0	47.41973840665874	325.1923745116612	VDR;PRKCD
Hippo/YAP1 Signaling	2/31	0.0010512841071621476	0.014191770784633287	0	0	47.41973840665874	325.1923745116612	CDH1;STK4
Proteins Involved in Hepatocellular Carcinoma	3/130	0.0010558429030142927	0.014191770784633287	0	0	16.73959505061867	114.72340639150858	EP300;STK4;JAK2
Apoptosis Block in Acute Myeloid Leukemia Cell	2/32	0.0011202887088092445	0.01462776971216642	0	0	45.836781609195405	311.42283384712533	KMT2A;JAK2
Proteins Involved in Acute Myeloid Leukemia	2/34	0.0012646591825652726	0.015620249903576475	0	0	42.9676724137931	286.72124195111644	KMT2A;JAK2
TSLP Signaling in Bronchial Epithelial Cell in Asthma	2/34	0.0012646591825652726	0.015620249903576475	0	0	42.9676724137931	286.72124195111644	VDR;JAK2
NOTCH1 Signaling in Breast Cancer	2/35	0.0013400124367637719	0.01611541272634326	0	0	41.66353187042842	275.6074457457441	CDH1;EP300
Estrogen Effects on Pregnancy Gingivitis	2/36	0.0014174693130427694	0.01660983271950117	0	0	40.436105476673426	265.2156512854863	CDH1;EP300
TERT Activation in Cancer	2/37	0.0014970235354745522	0.01710349389279676	0	0	39.278817733990145	255.48028924599194	MAX;EP300
TRPM4/6/7/8 Signaling in Arterial Hypertension (Hypothesis)	2/39	0.001662398983033374	0.01808848417252981	0	0	37.15191053122088	237.7534117911538	PRKCD;JAK2
Podocyte Dysfunction in Diabetic Nephropathy	2/39	0.001662398983033374	0.01808848417252981	0	0	37.15191053122088	237.7534117911538	PRKCB;JAK2
Proteins Involved in T-Cell Acute Lymphoblastic Leukemia	2/40	0.0017482077236044978	0.018579789062494315	0	0	36.172413793103445	229.6645937348641	KMT2A;JAK2
Proteins Involved in Dilated Cardiomyopathy	3/167	0.002164519358696435	0.022481485157369793	0	0	12.938806620209059	79.38678484963106	CDH1;PRKCD;STK4
Proteins Involved in Diabetic Nephropathy	3/175	0.0024720426798573326	0.02487794686005347	0	0	12.332018272425248	74.02553525217527	VDR;PRKCB;JAK2
Negative Acute Phase Proteins Synthesis	2/48	0.0025087632834003815	0.02487794686005347	0	0	29.869565217391305	178.85792193078825	VDR;JAK2
Insulin Resistance in Hepatocytes	2/49	0.002613000983112837	0.02487794686005347	0	0	29.23257520176082	173.85360581456808	PRKCD;JAK2
Mesangial Cell Dysfunction in Diabetic Nephropathy	2/49	0.002613000983112837	0.02487794686005347	0	0	29.23257520176082	173.85360581456808	PRKCB;PRKCD
Neutrophil Activation via FCGR3B	2/50	0.0027192556482504363	0.025336807499435357	0	0	28.62212643678161	169.08226656127547	PRKCB;PRKCD
ESR1 Signaling in Breast Cancer	2/51	0.0028275211870267027	0.025336807499435357	0	0	28.036593947923997	164.52868226245067	EP300;JAK2
Myocardial Remodeling	2/51	0.0028275211870267027	0.025336807499435357	0	0	28.036593947923997	164.52868226245067	PRKCD;ARRB1
Adipokines and Cytokines in Insulin Resistance in Skeletal Muscles	2/53	0.003050060586094204	0.02680534015086637	0	0	26.934415145368494	156.02012683130314	PRKCD;JAK2
G0/G1 Cell Cycle Phase Transition Activation in Cancer	2/54	0.0031643223277353994	0.02728481705235995	0	0	26.415119363395224	152.0405762035586	EP300;JAK2
Th1-Cell Function in Systemic Lupus Erythematosus	2/55	0.003280570706943304	0.027763348390242408	0	0	25.915419648666234	148.2294073291968	PRKCD;JAK2
Neutrophil Chemotaxis	2/56	0.003398799697079565	0.02824093566482475	0	0	25.434227330779056	144.5766162187934	PRKCB;PRKCD
Neutrophil Activation via Adherence on Endothelial Cells	2/57	0.003519003283445158	0.028717580366686382	0	0	24.9705329153605	141.07296061152428	PRKCB;PRKCD
Proteins with Altered Expression in Cancer-Associated Evading of Growth Suppressors	2/58	0.003641175466029308	0.029193283999568314	0	0	24.523399014778324	137.7098895888601	CDH1;STK4
Steroids Induced Cataract	2/59	0.00376531025589527	0.02963950943850059	0	0	24.091954022988507	134.47948084141416	CDH1;EP300
Proliferative Diabetic Retinopathy	2/60	0.0038914016768272115	0.02963950943850059	0	0	23.67538644470868	131.3743845648751	PRKCB;JAK2
Mucinous Ovarian Carcinoma	2/60	0.0038914016768272115	0.02963950943850059	0	0	23.67538644470868	131.3743845648751	EP300;JAK2
Proteins Involved in Diffuse Large-B-Cell Lymphoma	2/61	0.0040194437674711024	0.030112881995644162	0	0	23.272939801285798	128.38777321660814	KMT2A;PRKCB
Neutrophil Degranulation via FPR1 Signaling	2/62	0.004149430576332218	0.030585318925545543	0	0	22.883908045977012	125.51329647647898	PRKCD;PADI4
Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway	2/64	0.004415214615800143	0.0315273918659479	0	0	22.14349276974416	120.07749245655843	EP300;JAK2
Neutrophil Degranulation via FPR1/IL8	2/64	0.004415214615800143	0.0315273918659479	0	0	22.14349276974416	120.07749245655843	PRKCB;PRKCD
B-Cell Activation in Systemic Lupus Erythematosus	2/65	0.00455100000897125	0.03199703083230556	0	0	21.790914066776136	117.50550561626433	PRKCB;JAK2
Neutrophil Recruitment and Priming	2/66	0.004688706448142651	0.032465740103048354	0	0	21.44935344827586	115.02427159714598	PRKCB;JAK2
STAT3 and NFkB Activate Inflammation-Induced Tumorigenesis	2/67	0.004828328046458851	0.03293352115271187	0	0	21.118302387267903	112.62929246148852	CDH1;JAK2
B-Cells Function in Systemic Scleroderma	2/69	0.005113293237096843	0.034364338372842015	0	0	20.485846628924342	108.08151613676682	PRKCB;JAK2
Low-Grade Serous Ovarian Carcinoma	2/70	0.005258625119570298	0.034828864922371396	0	0	20.183569979716026	105.921067676316	EP300;JAK2
Humoral Immunity in Vitiligo	2/71	0.0054058487402184816	0.03525855461278779	0	0	19.89005497251374	103.83153308233095	PRKCB;JAK2
Proteins Involved in Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway	2/72	0.0055549582759753195	0.03525855461278779	0	0	19.604926108374386	101.8096431909553	CDH1;JAK2
Glioma Stem Cell Program Activation	2/72	0.0055549582759753195	0.03525855461278779	0	0	19.604926108374386	101.8096431909553	EP300;JAK2
Proteins Involved in Melanoma	3/238	0.005849326949877012	0.036182121885112176	0	0	8.997264437689969	46.25879338243835	CDH1;VDR;PRKCB
TAM Receptor Signaling Activation in Cancer	2/74	0.0058588118588584264	0.036182121885112176	0	0	19.058429118773947	97.95667503624674	CDH1;PRKCB
Endometrioid Ovarian Carcinoma	2/76	0.006170139526936201	0.03759671685079792	0	0	18.54147250698975	94.33963932823616	EP300;JAK2
Proplatelet Maturation	2/79	0.006651044056183717	0.03999377807468367	0	0	17.81639050604568	89.31323485812854	ZBTB16;JAK2
Atopic Dermatitis	2/81	0.006980855498419672	0.04084720025862005	0	0	17.36359668267132	86.20303089558485	CDH1;JAK2
Clear Cell Ovarian Carcinoma	2/81	0.006980855498419672	0.04084720025862005	0	0	17.36359668267132	86.20303089558485	EP300;JAK2
High-Grade Serous Ovarian Carcinoma	2/82	0.007148506609489397	0.04084720025862005	0	0	17.145689655172415	84.71431176469774	EP300;JAK2
Proteins Involved in Endometriosis	3/256	0.0071504945748131375	0.04084720025862005	0	0	8.34952004517222	41.2514195883804	CDH1;VDR;PRKCB
CHRNA7 -> IL8 Production	1/5	0.007726694289035996	0.04254336494083675	0	0	166.375	809.0939625056958	JAK2
ARRB1/ARRB2 and GPCRs Internalization	1/5	0.007726694289035996	0.04254336494083675	0	0	166.375	809.0939625056958	ARRB1
Genes with Mutations Associated with Osteoporosis	1/5	0.007726694289035996	0.04254336494083675	0	0	166.375	809.0939625056958	VDR
Epithelial to Mesenchymal Transition in Cancer: Overview	2/90	0.008554856511560106	0.04456997008546855	0	0	15.580721003134796	74.18380360792477	CDH1;JAK2
Diffuse Large-B-Cell Lymphoma	2/91	0.008738708384625295	0.04456997008546855	0	0	15.404881828748547	73.0190302211722	EP300;JAK2
Endometrioid Endometrial Cancer	2/92	0.008924332290442406	0.04456997008546855	0	0	15.23295019157088	71.88389235582319	EP300;JAK2
Proteins Involved in Spontaneous Abortion	2/93	0.009111722662175992	0.04456997008546855	0	0	15.064797271693823	70.77733246775645	CDH1;EP300
ESR1/ERBB Positive Luminal Breast Cancer	2/93	0.009111722662175992	0.04456997008546855	0	0	15.064797271693823	70.77733246775645	EP300;JAK2
M-cell: Motilin Release	1/6	0.009265092249714469	0.04456997008546855	0	0	133.09333333333333	623.0766346487915	ARRB1
Prolactin Induced Dopamin Synthesis by TIDA Neurons (Negative Feedback)	1/6	0.009265092249714469	0.04456997008546855	0	0	133.09333333333333	623.0766346487915	JAK2
Vitamin D and Folate in Multiple Sclerosis	1/6	0.009265092249714469	0.04456997008546855	0	0	133.09333333333333	623.0766346487915	VDR
IGF1R -> ARRB1/ERK1/3 Signaling	1/6	0.009265092249714469	0.04456997008546855	0	0	133.09333333333333	623.0766346487915	ARRB1
IL11R -> STAT3 Signaling	1/6	0.009265092249714469	0.04456997008546855	0	0	133.09333333333333	623.0766346487915	JAK2
KIT -> STAT Signaling	1/6	0.009265092249714469	0.04456997008546855	0	0	133.09333333333333	623.0766346487915	JAK2
Genes with Mutations Associated with Urolithiasis	1/6	0.009265092249714469	0.04456997008546855	0	0	133.09333333333333	623.0766346487915	VDR
Follicular Lymphoma	2/97	0.009878837910766144	0.04702738463770967	0	0	14.427586206896551	66.61736514007372	EP300;JAK2
ROS in Neutrophil Mediated Cell Damage	1/7	0.010801182772692638	0.047923694438063456	0	0	110.90555555555555	502.1914056148727	JAK2
CSF2 -> STAT Signaling	1/7	0.010801182772692638	0.047923694438063456	0	0	110.90555555555555	502.1914056148727	JAK2
Ca2+ Absorption Decline in Intestine in Osteoporosis	1/7	0.010801182772692638	0.047923694438063456	0	0	110.90555555555555	502.1914056148727	VDR
Ca2+ Reabsorption Decline in Kidney	1/7	0.010801182772692638	0.047923694438063456	0	0	110.90555555555555	502.1914056148727	VDR
IL6ST -> STAT5B Signaling	1/7	0.010801182772692638	0.047923694438063456	0	0	110.90555555555555	502.1914056148727	JAK2
Folate Cycle and Homocysteine Overproduction	1/7	0.010801182772692638	0.047923694438063456	0	0	110.90555555555555	502.1914056148727	VDR
IL6 Overexpression After Contraction in Skeletal Muscles in Muscular Dystrophies	1/7	0.010801182772692638	0.047923694438063456	0	0	110.90555555555555	502.1914056148727	EP300
T-Cell Acute Lymphoblastic Leukemia	2/103	0.011081566043114378	0.048694958477916064	0	0	13.566404916353704	61.082361912602465	EP300;JAK2
Mantle Cell Lymphoma	2/105	0.011496181765014754	0.049448077654477174	0	0	13.301640441914964	59.401672032660606	PRKCB;JAK2
Breast Cancer	2/108	0.01213080582261541	0.049448077654477174	0	0	12.923227065712426	57.017369905230545	EP300;JAK2
Leptin -> NO Production/Vasodilation	1/8	0.012334969042911155	0.049448077654477174	0	0	95.05714285714286	417.8062796500496	JAK2
non-Genomic Rapid Actions of Vitamin D in Vitamin D Biology	1/8	0.012334969042911155	0.049448077654477174	0	0	95.05714285714286	417.8062796500496	VDR
CXCR4 -> ARRB1 Signaling	1/8	0.012334969042911155	0.049448077654477174	0	0	95.05714285714286	417.8062796500496	ARRB1
HGFR -> STAT Signaling	1/8	0.012334969042911155	0.049448077654477174	0	0	95.05714285714286	417.8062796500496	JAK2
IL31R -> STAT Signaling	1/8	0.012334969042911155	0.049448077654477174	0	0	95.05714285714286	417.8062796500496	JAK2
IL6R -> STAT Signaling	1/8	0.012334969042911155	0.049448077654477174	0	0	95.05714285714286	417.8062796500496	JAK2
NOTCH -> EP300/ASCL Signaling	1/8	0.012334969042911155	0.049448077654477174	0	0	95.05714285714286	417.8062796500496	EP300
Dentin Formation in Rothmund-Thomson Syndrome	1/8	0.012334969042911155	0.049448077654477174	0	0	95.05714285714286	417.8062796500496	EP300
Hepatocellular Carcinoma	2/112	0.013000452731669755	0.05069575688084006	0	0	12.450783699059562	54.070903578467814	EP300;JAK2
Leptin -> CD25/IL6/IL10 Production	1/9	0.013866454289070039	0.05069575688084006	0	0	83.17083333333333	355.82833874131705	JAK2
Vitamin D Activates Transcription	1/9	0.013866454289070039	0.05069575688084006	0	0	83.17083333333333	355.82833874131705	VDR
GPCRs Desentization	1/9	0.013866454289070039	0.05069575688084006	0	0	83.17083333333333	355.82833874131705	ARRB1
IGF1R -> STAT Signaling	1/9	0.013866454289070039	0.05069575688084006	0	0	83.17083333333333	355.82833874131705	JAK2
IL12R -> STAT Signaling	1/9	0.013866454289070039	0.05069575688084006	0	0	83.17083333333333	355.82833874131705	JAK2
IL27R -> STAT Signaling	1/9	0.013866454289070039	0.05069575688084006	0	0	83.17083333333333	355.82833874131705	JAK2
IL3R -> STAT Signaling	1/9	0.013866454289070039	0.05069575688084006	0	0	83.17083333333333	355.82833874131705	JAK2
IL5R -> STAT Signaling	1/9	0.013866454289070039	0.05069575688084006	0	0	83.17083333333333	355.82833874131705	JAK2
InsulinR -> STAT Signaling	1/9	0.013866454289070039	0.05069575688084006	0	0	83.17083333333333	355.82833874131705	JAK2
PDGFR -> STAT Signaling	1/9	0.013866454289070039	0.05069575688084006	0	0	83.17083333333333	355.82833874131705	JAK2
Pancreatic Ductal Carcinoma	2/117	0.014124768767146065	0.051230312115759936	0	0	11.906446776611695	50.71938407594053	EP300;JAK2
Metastatic Colorectal Cancer	2/121	0.015053614496342767	0.05290081418322988	0	0	11.503911909591423	48.271992142820785	CDH1;JAK2
Multiple Myeloma	2/121	0.015053614496342767	0.05290081418322988	0	0	11.503911909591423	48.271992142820785	EP300;JAK2
IL12 Antitumor Effect is Blocked in Cancer	1/10	0.015395641764484845	0.05290081418322988	0	0	73.92592592592592	308.5424792813036	JAK2
Histone Ubiquitylation	1/10	0.015395641764484845	0.05290081418322988	0	0	73.92592592592592	308.5424792813036	CTR9
IL12R -> NF-kB/NFATC Signaling	1/10	0.015395641764484845	0.05290081418322988	0	0	73.92592592592592	308.5424792813036	JAK2
ProlactinR -> STAT Signaling	1/10	0.015395641764484845	0.05290081418322988	0	0	73.92592592592592	308.5424792813036	JAK2
MGAM Inhibitors	1/10	0.015395641764484845	0.05290081418322988	0	0	73.92592592592592	308.5424792813036	PRKCB
Mast-Cell Activation without Degranulation through CXCR4 Signaling	1/11	0.016922534733464	0.05563739836829531	0	0	66.53	271.3831303578043	JAK2
Ca2+ Reabsorption Decline in Intestine	1/11	0.016922534733464	0.05563739836829531	0	0	66.53	271.3831303578043	VDR
Ca2+ Reabsorption Dysregulation in Urolithiasis	1/11	0.016922534733464	0.05563739836829531	0	0	66.53	271.3831303578043	VDR
TNFRSF1A -> STAT Signaling	1/11	0.016922534733464	0.05563739836829531	0	0	66.53	271.3831303578043	JAK2
EPHA2 Mutations in Cataract	1/11	0.016922534733464	0.05563739836829531	0	0	66.53	271.3831303578043	CDH1
IL6/JAK/STAT3 Signaling in Cholesteatoma	1/11	0.016922534733464	0.05563739836829531	0	0	66.53	271.3831303578043	JAK2
Ovarian Cancer	2/130	0.01723720788834862	0.05626717146410943	0	0	10.690193965517242	43.409510093596516	EP300;JAK2
Neuroblastoma	2/131	0.01748771629334441	0.056680045007506355	0	0	10.606789628441593	42.91779222718881	MAX;EP300
Mast-Cell Activation without Degranulation through KIT/F2R Signaling	1/12	0.018447136470887412	0.05774206415887361	0	0	60.47878787878788	241.48249384895686	JAK2
SCF/FBXO11 Complex	1/12	0.018447136470887412	0.05774206415887361	0	0	60.47878787878788	241.48249384895686	CDH1
ARRB1/ARRB2 non-CanonicalSignaling and HedgehogFamily	1/12	0.018447136470887412	0.05774206415887361	0	0	60.47878787878788	241.48249384895686	ARRB1
IL23R -> STAT3/NF-kB Signaling	1/12	0.018447136470887412	0.05774206415887361	0	0	60.47878787878788	241.48249384895686	JAK2
Cochlear Inflammation (Noise-Induced)	1/12	0.018447136470887412	0.05774206415887361	0	0	60.47878787878788	241.48249384895686	JAK2
B-Cell Differentiation Inhibition by Dioxin	1/13	0.019969450260865367	0.06076490697667678	0	0	55.43611111111111	216.95208467294643	JAK2
STAT3 Facilitates the Function of Treg Cells and Cancer Progression	1/13	0.019969450260865367	0.06076490697667678	0	0	55.43611111111111	216.95208467294643	JAK2
FGFR1 -> STAT Signaling	1/13	0.019969450260865367	0.06076490697667678	0	0	55.43611111111111	216.95208467294643	JAK2
IL1R -> STAT3 Signaling	1/13	0.019969450260865367	0.06076490697667678	0	0	55.43611111111111	216.95208467294643	PRKCD
Proteins Involved in Ulcerative Colitis	2/141	0.020077682611549658	0.06076490697667678	0	0	9.83874968990325	38.451274167420166	CDH1;JAK2
Nociception Expression Targets Signaling	2/143	0.020613933088894545	0.06077631675891007	0	0	9.698214722426021	37.64641419311877	EP300;JAK2
Melanoma	2/145	0.02115617583087612	0.06077631675891007	0	0	9.561610802990113	36.867882815979016	CDH1;JAK2
Proteins Involved in Urolithiasis	1/14	0.02148947938555657	0.06077631675891007	0	0	51.16923076923077	196.4996601316088	VDR
PRL and CSH Action in Mammary Gland	1/14	0.02148947938555657	0.06077631675891007	0	0	51.16923076923077	196.4996601316088	JAK2
FGFR3 -> STAT Signaling	1/14	0.02148947938555657	0.06077631675891007	0	0	51.16923076923077	196.4996601316088	JAK2
Ca2+/Pi Reabsorption Decline in Kidney in Hyperparathyroidism	1/14	0.02148947938555657	0.06077631675891007	0	0	51.16923076923077	196.4996601316088	VDR
Ca2+/Pi Reabsorption Decline in Kidney in Hypoparathyroidism	1/14	0.02148947938555657	0.06077631675891007	0	0	51.16923076923077	196.4996601316088	VDR
NOTCH Signaling in Multiple Myeloma	1/14	0.02148947938555657	0.06077631675891007	0	0	51.16923076923077	196.4996601316088	EP300
Oxidative Stress in Vitiligo	1/14	0.02148947938555657	0.06077631675891007	0	0	51.16923076923077	196.4996601316088	JAK2
Immunoglobulin Genes Transcriptional Activation	1/15	0.023007227131928758	0.06077631675891007	0	0	47.51190476190476	179.21238137059572	JAK2
PTPRN/STAT5 in Insulin Synthesis in beta-Cell (Rodent Model)	1/15	0.023007227131928758	0.06077631675891007	0	0	47.51190476190476	179.21238137059572	JAK2
TLR3 Role in Retinal Pigment Epithelial Cell	1/15	0.023007227131928758	0.06077631675891007	0	0	47.51190476190476	179.21238137059572	JAK2
Vitamin D Represses Transcription	1/15	0.023007227131928758	0.06077631675891007	0	0	47.51190476190476	179.21238137059572	VDR
Deacetylases Activation in Histone Deacetylation in Cancer	1/15	0.023007227131928758	0.06077631675891007	0	0	47.51190476190476	179.21238137059572	HDAC5
Vitamins Insufficiency Causes Homocysteine High Level Synthesis	1/15	0.023007227131928758	0.06077631675891007	0	0	47.51190476190476	179.21238137059572	VDR
Chromosome Condensation	1/15	0.023007227131928758	0.06077631675891007	0	0	47.51190476190476	179.21238137059572	STK4
Genes with Mutations in Cancer-Associated Histone Methylation	1/15	0.023007227131928758	0.06077631675891007	0	0	47.51190476190476	179.21238137059572	KMT2A
Proteins with Altered Expression in Cancer-Associated Histone Deacetylation	1/15	0.023007227131928758	0.06077631675891007	0	0	47.51190476190476	179.21238137059572	EP300
EphrinR -> STAT Signaling	1/15	0.023007227131928758	0.06077631675891007	0	0	47.51190476190476	179.21238137059572	JAK2
GLP1R -> ARRB1 Signaling	1/15	0.023007227131928758	0.06077631675891007	0	0	47.51190476190476	179.21238137059572	ARRB1
Desmosomes Role in Dilated Cardiomyopathy	1/15	0.023007227131928758	0.06077631675891007	0	0	47.51190476190476	179.21238137059572	CDH1
KISS1 Production Impairment in Hypogonadotropic hypogonadism	1/15	0.023007227131928758	0.06077631675891007	0	0	47.51190476190476	179.21238137059572	JAK2
Proteins Involved in Hyperparathyroidism	1/16	0.024522696784534302	0.06331566344933433	0	0	44.34222222222222	164.42788585185278	VDR
STAT3 Inhibits Maturation of Dendritic Cells and Facilitates Cancer Progression	1/16	0.024522696784534302	0.06331566344933433	0	0	44.34222222222222	164.42788585185278	JAK2
Frizzled Receptors -> ARRB1/ARRB2 Canonical Signaling	1/16	0.024522696784534302	0.06331566344933433	0	0	44.34222222222222	164.42788585185278	ARRB1
Hedgehog Family -> ARRB1/ARRB2 Canonical Signaling	1/16	0.024522696784534302	0.06331566344933433	0	0	44.34222222222222	164.42788585185278	ARRB1
SOCS3 and PTPN1 in Hypothalamic Neuron Insensitivity to Insulin and Leptin	1/17	0.026035891626597026	0.06396990577072495	0	0	41.56875	151.65440789573447	JAK2
P-cell Activation	1/17	0.026035891626597026	0.06396990577072495	0	0	41.56875	151.65440789573447	JAK2
Vascularization in Hepatocellular Carcinoma	1/17	0.026035891626597026	0.06396990577072495	0	0	41.56875	151.65440789573447	EP300
Dexamethasone Induced Neurotoxicity	1/17	0.026035891626597026	0.06396990577072495	0	0	41.56875	151.65440789573447	EP300
Histone Phosphorylation	1/17	0.026035891626597026	0.06396990577072495	0	0	41.56875	151.65440789573447	STK4
Frizzled Receptors -> ARRB1/ARRB2 non-Canonical Signaling	1/17	0.026035891626597026	0.06396990577072495	0	0	41.56875	151.65440789573447	ARRB1
IL6R -> CEBP/ELK/SRF Signaling	1/17	0.026035891626597026	0.06396990577072495	0	0	41.56875	151.65440789573447	JAK2
TGFBR -> ATF/GADD/MAX/TP53 Signaling	1/17	0.026035891626597026	0.06396990577072495	0	0	41.56875	151.65440789573447	MAX
Leptin Role in Endometriosis	1/17	0.026035891626597026	0.06396990577072495	0	0	41.56875	151.65440789573447	JAK2
Proteins Involved in Adhesion, Migration and Invasion of Endometriotic Cell	1/18	0.027546814940669486	0.06556715847857268	0	0	39.12156862745098	140.51952455455398	CDH1
Desmosome Assembly	1/18	0.027546814940669486	0.06556715847857268	0	0	39.12156862745098	140.51952455455398	CDH1
Methylases in Histone Methylation Cancer	1/18	0.027546814940669486	0.06556715847857268	0	0	39.12156862745098	140.51952455455398	KMT2A
Cortisol Signaling in Arterial Hypertension	1/18	0.027546814940669486	0.06556715847857268	0	0	39.12156862745098	140.51952455455398	EP300
FOXA2 Signaling in Prostate Cancer	1/18	0.027546814940669486	0.06556715847857268	0	0	39.12156862745098	140.51952455455398	EP300
IL6/IL12 Signaling Activates Immune System in Multiple Sclerosis	1/18	0.027546814940669486	0.06556715847857268	0	0	39.12156862745098	140.51952455455398	JAK2
SOCS in Negative Feedback Regulation in Myocarditis	1/19	0.02905547000861942	0.06672537584894007	0	0	36.946296296296296	130.736261970552	JAK2
Histone Sumoylation	1/19	0.02905547000861942	0.06672537584894007	0	0	36.946296296296296	130.736261970552	EP300
Proteins with Altered Expression in Cancer-Associated Enabling of Replicative Immortality	1/19	0.02905547000861942	0.06672537584894007	0	0	36.946296296296296	130.736261970552	EP300
Corneodesmosomes in Atopic Dermatitis	1/19	0.02905547000861942	0.06672537584894007	0	0	36.946296296296296	130.736261970552	CDH1
Genes with Mutations Associated with Psoriasis	1/19	0.02905547000861942	0.06672537584894007	0	0	36.946296296296296	130.736261970552	VDR
Ions Reabsorption Dysregulation in Nephrolithiasis	1/19	0.02905547000861942	0.06672537584894007	0	0	36.946296296296296	130.736261970552	VDR
Leptin in Insulin Synthesis and Secretion	1/19	0.02905547000861942	0.06672537584894007	0	0	36.946296296296296	130.736261970552	JAK2
Thyrotropin Releasing Hormone (TRH) Hypothalamic Release in non-Autoimmune Hypothyroidism	1/20	0.030561860107418466	0.06779985470432155	0	0	35.0	122.08008572013848	JAK2
Double Strand DNA Homologous Repair	1/20	0.030561860107418466	0.06779985470432155	0	0	35.0	122.08008572013848	UIMC1
Histone Acetylation	1/20	0.030561860107418466	0.06779985470432155	0	0	35.0	122.08008572013848	EP300
MicroRNAs in Epithelial to Mesenchymal Transition in Cancer	1/20	0.030561860107418466	0.06779985470432155	0	0	35.0	122.08008572013848	CDH1
Nuclear Lamina Cleavage	1/20	0.030561860107418466	0.06779985470432155	0	0	35.0	122.08008572013848	PRKCD
EGFR/ERBB -> STAT Signaling	1/20	0.030561860107418466	0.06779985470432155	0	0	35.0	122.08008572013848	JAK2
HPV E1 and E2 Expression in Early Phase of Cancer	1/20	0.030561860107418466	0.06779985470432155	0	0	35.0	122.08008572013848	CDH1
TRPM7/8 in Pancreatic Adenocarcinoma	1/21	0.032065988516399045	0.06945097986727186	0	0	33.248333333333335	114.37291539918965	JAK2
Dexamethasone Induced Diabetes	1/21	0.032065988516399045	0.06945097986727186	0	0	33.248333333333335	114.37291539918965	EP300
Dexamethasone Induced Osteoporosis	1/21	0.032065988516399045	0.06945097986727186	0	0	33.248333333333335	114.37291539918965	EP300
T-Cell Receptor -> STAT Signaling	1/21	0.032065988516399045	0.06945097986727186	0	0	33.248333333333335	114.37291539918965	JAK2
IFN-gamma/TNF-alpha Mediated Cell Proliferation in Psoriasis	1/21	0.032065988516399045	0.06945097986727186	0	0	33.248333333333335	114.37291539918965	JAK2
SIRT2 Signaling in Aging	1/22	0.03356785849795628	0.07102088580354639	0	0	31.663492063492065	107.4717897739846	EP300
DNMT and MBD Families Activation in DNA Methylation in Cancer	1/22	0.03356785849795628	0.07102088580354639	0	0	31.663492063492065	107.4717897739846	CDH1
Estrogens/ESR1 Genomic Canonical Signaling	1/22	0.03356785849795628	0.07102088580354639	0	0	31.663492063492065	107.4717897739846	EP300
Epithelial Cell in the Innate Immune Response in Ulcerative Colitis	1/22	0.03356785849795628	0.07102088580354639	0	0	31.663492063492065	107.4717897739846	CDH1
Lymphoma, GCB Subtype	1/22	0.03356785849795628	0.07102088580354639	0	0	31.663492063492065	107.4717897739846	EP300
AHR Signaling in M1 Macrophages Function	1/23	0.03506747333209365	0.07154390764628037	0	0	30.222727272727273	101.26068146954859	JAK2
Proteins Involved in Chronic Myeloid Leukemia	1/23	0.03506747333209365	0.07154390764628037	0	0	30.222727272727273	101.26068146954859	JAK2
HRH2/4 -> IL6/10 Production	1/23	0.03506747333209365	0.07154390764628037	0	0	30.222727272727273	101.26068146954859	EP300
Proteins with Altered Expression in Endometrial Cancer	1/23	0.03506747333209365	0.07154390764628037	0	0	30.222727272727273	101.26068146954859	CDH1
BDNF Upregulation Triggered by Seizures	1/23	0.03506747333209365	0.07154390764628037	0	0	30.222727272727273	101.26068146954859	JAK2
beta-Catenin/Androgen Receptor Signaling in Prostate Cancer	1/23	0.03506747333209365	0.07154390764628037	0	0	30.222727272727273	101.26068146954859	CDH1
NGFR -> MEF Signaling	1/23	0.03506747333209365	0.07154390764628037	0	0	30.222727272727273	101.26068146954859	EP300
Hodgkin and Reed-Sternberg Cells Reprogramming	1/23	0.03506747333209365	0.07154390764628037	0	0	30.222727272727273	101.26068146954859	JAK2
Proteins Involved in Male Infertility	2/193	0.0358670030910624	0.07233822587090201	0	0	7.141361256544503	23.766004213100285	KDM3A;ZBTB16
Apoptosis of Cochlear Hair Cells (Noise-Induced, Mouse Model)	1/24	0.03656483627172508	0.07233822587090201	0	0	28.907246376811596	95.64448851318153	JAK2
WNT Signaling in Melanoma	1/24	0.03656483627172508	0.07233822587090201	0	0	28.907246376811596	95.64448851318153	CDH1
Mutations in Krebs Cycle Enzymes in Cancer	1/24	0.03656483627172508	0.07233822587090201	0	0	28.907246376811596	95.64448851318153	TET2
HIF1 Signaling	1/24	0.03656483627172508	0.07233822587090201	0	0	28.907246376811596	95.64448851318153	EP300
Microangiopathy in Diabetic Neuropathy	1/24	0.03656483627172508	0.07233822587090201	0	0	28.907246376811596	95.64448851318153	PRKCB
NOTCH Signaling in Hepatocellular Carcinoma	1/24	0.03656483627172508	0.07233822587090201	0	0	28.907246376811596	95.64448851318153	EP300
ADRA2C/ADRB2 -> Vasoconstriction	1/25	0.03805995059128532	0.07401445710730806	0	0	27.70138888888889	90.5445579257637	ARRB1
AHR Signaling in Th17 Cells Function	1/25	0.03805995059128532	0.07401445710730806	0	0	27.70138888888889	90.5445579257637	JAK2
Leptin and CCK8 Activate Nodose Ganglia Neuron	1/25	0.03805995059128532	0.07401445710730806	0	0	27.70138888888889	90.5445579257637	JAK2
AGTR1 -> ARRB1/ARRB2 Signaling	1/25	0.03805995059128532	0.07401445710730806	0	0	27.70138888888889	90.5445579257637	ARRB1
ADRA2C/ADRB2 -> Synaptic Endocytosis	1/26	0.03955281953600642	0.07531516053314556	0	0	26.592	85.8953057509563	ARRB1
Kidney Cells Cilia Organization	1/26	0.03955281953600642	0.07531516053314556	0	0	26.592	85.8953057509563	CDH1
IL23A and IL17A Provoke Cancer-Associated Inflammation	1/26	0.03955281953600642	0.07531516053314556	0	0	26.592	85.8953057509563	JAK2
Hedgehog Family Signaling	1/26	0.03955281953600642	0.07531516053314556	0	0	26.592	85.8953057509563	ARRB1
Endothelial Cell Dysfunction in Progressive Diabetic Nephropathy	1/26	0.03955281953600642	0.07531516053314556	0	0	26.592	85.8953057509563	JAK2
IL6 Expression Targets -> Nociception	1/27	0.041043446358547446	0.07652381214075449	0	0	25.567948717948717	81.6416333934617	JAK2
Cancer Cells Inhibit Adipocyte Differentiation	1/27	0.041043446358547446	0.07652381214075449	0	0	25.567948717948717	81.6416333934617	JAK2
TGFBR -> MEF/MYOD/MYOG Signaling	1/27	0.041043446358547446	0.07652381214075449	0	0	25.567948717948717	81.6416333934617	EP300
MIF Role in Cholesteatoma	1/27	0.041043446358547446	0.07652381214075449	0	0	25.567948717948717	81.6416333934617	JAK2
Osteoblast Function Decline in Gout	1/27	0.041043446358547446	0.07652381214075449	0	0	25.567948717948717	81.6416333934617	VDR
I-cell: CCK-8 Secretion and Regulation of Eating Behavior	1/28	0.04253183431893138	0.07652381214075449	0	0	24.619753086419752	77.73693045847051	JAK2
Proteins with Altered Expression in Breast Cancer	1/28	0.04253183431893138	0.07652381214075449	0	0	24.619753086419752	77.73693045847051	CDH1
Proteins with Altered Expression in Prostate Cancer	1/28	0.04253183431893138	0.07652381214075449	0	0	24.619753086419752	77.73693045847051	CDH1
EZH2 Methyltransferase Role in Cancer	1/28	0.04253183431893138	0.07652381214075449	0	0	24.619753086419752	77.73693045847051	CDH1
ERBB2/3 -> EP300/ETS/ETV/SP1 Signaling	1/28	0.04253183431893138	0.07652381214075449	0	0	24.619753086419752	77.73693045847051	EP300
Hypothyroidism, Secondary (Central)	1/28	0.04253183431893138	0.07652381214075449	0	0	24.619753086419752	77.73693045847051	JAK2
Il17 Signaling Related Neutrophilia in Asthma	1/28	0.04253183431893138	0.07652381214075449	0	0	24.619753086419752	77.73693045847051	JAK2
Nicotine anti-Inflammatory Effect in Ulcerative Colitis	1/28	0.04253183431893138	0.07652381214075449	0	0	24.619753086419752	77.73693045847051	JAK2
PHOX2B Effects in Neuroblastoma	1/28	0.04253183431893138	0.07652381214075449	0	0	24.619753086419752	77.73693045847051	EP300
Primary Mediastinal B-cell Lymphoma (PMBL) Subtype	1/29	0.04401798665976609	0.0779698445872601	0	0	23.739285714285714	74.14151494993529	JAK2
AHR Signaling in Tr1 Cells Function	1/29	0.04401798665976609	0.0779698445872601	0	0	23.739285714285714	74.14151494993529	JAK2
RARA Signaling in Acute Myeloid Leukemia (M3)	1/29	0.04401798665976609	0.0779698445872601	0	0	23.739285714285714	74.14151494993529	JAK2
CD4+ T-Cell Death in HIV	1/29	0.04401798665976609	0.0779698445872601	0	0	23.739285714285714	74.14151494993529	JAK2
Thyroid Hormones in Adipose Tissue Metabolism	1/30	0.0455019066193127	0.07817432828957106	0	0	22.919540229885058	70.82140338003367	JAK2
Thrombopoietin Receptors Signaling in Platelet Maturation	1/30	0.0455019066193127	0.07817432828957106	0	0	22.919540229885058	70.82140338003367	JAK2
Thyroid Hormones Common Genomic Effects in Hyperthyroidism	1/30	0.0455019066193127	0.07817432828957106	0	0	22.919540229885058	70.82140338003367	VDR
Adherens Junction Assembly (Cadherins)	1/30	0.0455019066193127	0.07817432828957106	0	0	22.919540229885058	70.82140338003367	CDH1
Intraflagellar Transport: BBSome Interaction	1/30	0.0455019066193127	0.07817432828957106	0	0	22.919540229885058	70.82140338003367	ARRB1
Persistent Double Strand DNA Homologous Repair in Cancer	1/30	0.0455019066193127	0.07817432828957106	0	0	22.919540229885058	70.82140338003367	UIMC1
Genes with Mutations Associated with Vitiligo	1/30	0.0455019066193127	0.07817432828957106	0	0	22.919540229885058	70.82140338003367	VDR
Mast-Cell Related Chemokines Signaling in Asthma	1/30	0.0455019066193127	0.07817432828957106	0	0	22.919540229885058	70.82140338003367	JAK2
Th17-Cell Numbers Reduction in HIV	1/31	0.04698359743176254	0.08041761807608794	0	0	22.154444444444444	67.74733246608147	JAK2
B-Cell Activation in Crohn's Disease	1/32	0.048463062337042354	0.08112681131145918	0	0	21.438709677419354	64.89397456016435	JAK2
IGF1R -> MEF/MYOD/MYOG Signaling	1/32	0.048463062337042354	0.08112681131145918	0	0	21.438709677419354	64.89397456016435	EP300
Endothelial Cell Dysfunction in Arterial Hypertension	1/32	0.048463062337042354	0.08112681131145918	0	0	21.438709677419354	64.89397456016435	PRKCD
FOXO1 and SREBP-1C Role in beta-Cell Suppression (Rodent Model)	1/32	0.048463062337042354	0.08112681131145918	0	0	21.438709677419354	64.89397456016435	JAK2
Hereditary Breast and Ovarian Cancer Syndrome	1/32	0.048463062337042354	0.08112681131145918	0	0	21.438709677419354	64.89397456016435	EP300
non-Hereditary Genetic Rearrangements in Neuroblastoma	1/32	0.048463062337042354	0.08112681131145918	0	0	21.438709677419354	64.89397456016435	MAX
Persisted DNA Repair Triggers Genomic Instability	1/33	0.04994030455802936	0.0820961121691346	0	0	20.767708333333335	62.2393036656038	UIMC1
Thyroid Stimulating Hormone (TSH) Resistance in Congenital Hypothyroidism	1/33	0.04994030455802936	0.0820961121691346	0	0	20.767708333333335	62.2393036656038	JAK2
Autocrine Cytokine/Chemokine Loops in Systemic Scleroderma	1/33	0.04994030455802936	0.0820961121691346	0	0	20.767708333333335	62.2393036656038	JAK2
Leukocyte Migration toward the Endothelial Cell in Ulcerative Colitis	1/33	0.04994030455802936	0.0820961121691346	0	0	20.767708333333335	62.2393036656038	JAK2
Overt Hypothyroidism, Primary	1/33	0.04994030455802936	0.0820961121691346	0	0	20.767708333333335	62.2393036656038	JAK2
Proteins Involved in Breast Cancer Related to WNT Signaling Pathway	1/34	0.051415327328444255	0.08273522742640502	0	0	20.13737373737374	59.76407945997836	CDH1
Insulin Synthesis in beta-Cell	1/34	0.051415327328444255	0.08273522742640502	0	0	20.13737373737374	59.76407945997836	EP300
Leukotriene Effect on Vascular Endothelial Cell Response	1/34	0.051415327328444255	0.08273522742640502	0	0	20.13737373737374	59.76407945997836	CDH1
CCR5 Signaling in Macrophages	1/34	0.051415327328444255	0.08273522742640502	0	0	20.13737373737374	59.76407945997836	JAK2
Diabetes Induced Periodontitis	1/34	0.051415327328444255	0.08273522742640502	0	0	20.13737373737374	59.76407945997836	JAK2
OipA Signaling in Helicobacter Pylori Infection	1/34	0.051415327328444255	0.08273522742640502	0	0	20.13737373737374	59.76407945997836	CDH1
Preconditioning Ischemia	1/35	0.052888133852117436	0.08334440403592298	0	0	19.544117647058822	57.45142461157597	JAK2
Thyroid Stimulating Hormone (TSH) Secretion in Overt Hypothyroidism	1/35	0.052888133852117436	0.08334440403592298	0	0	19.544117647058822	57.45142461157597	PRKCB
WNT Signaling in Breast Cancer	1/35	0.052888133852117436	0.08334440403592298	0	0	19.544117647058822	57.45142461157597	CDH1
Androgen Receptor/Akt Signaling	1/35	0.052888133852117436	0.08334440403592298	0	0	19.544117647058822	57.45142461157597	EP300
Glucocorticoids in Insulin Resistance in Skeletal Muscles	1/35	0.052888133852117436	0.08334440403592298	0	0	19.544117647058822	57.45142461157597	EP300
Neurotrophic Factor Deprivation in Retinal Ganglion Cell Death	1/35	0.052888133852117436	0.08334440403592298	0	0	19.544117647058822	57.45142461157597	JAK2
Lipoxin A4/FPR2-Related Neutrophil Depression	1/36	0.05435872736369502	0.08336220941345177	0	0	18.984761904761903	55.2864763029152	PRKCB
Thymic Follicular Hyperplasia	1/36	0.05435872736369502	0.08336220941345177	0	0	18.984761904761903	55.2864763029152	VDR
Thyroid Dysfunction	1/36	0.05435872736369502	0.08336220941345177	0	0	18.984761904761903	55.2864763029152	JAK2
EPCAM in Cancer Cell Motility and Proliferation	1/36	0.05435872736369502	0.08336220941345177	0	0	18.984761904761903	55.2864763029152	CDH1
WNT Signaling Activation by Blocking of Tumor Suppressors	1/36	0.05435872736369502	0.08336220941345177	0	0	18.984761904761903	55.2864763029152	CDH1
Donohue Syndrome Progression (Hypothesis)	1/36	0.05435872736369502	0.08336220941345177	0	0	18.984761904761903	55.2864763029152	JAK2
Immune Sustem Activation in Hashimoto's Thyroiditis	1/36	0.05435872736369502	0.08336220941345177	0	0	18.984761904761903	55.2864763029152	VDR
Neutrophil Recruitment in Sinovium in Gout	1/36	0.05435872736369502	0.08336220941345177	0	0	18.984761904761903	55.2864763029152	JAK2
Endothelial Cell Dysfunction in Pyelonephritis	1/37	0.05582711106215124	0.08532772493445859	0	0	18.456481481481482	53.25609732919314	JAK2
Dedifferentiation and Metastatic Progression in Melanoma	1/38	0.05729328816000485	0.0872767756304074	0	0	17.956756756756757	51.348635190815486	CDH1
Aryl Hydrocarbon Receptor Genomic and non-Genomic Signaling	1/39	0.05875726186108227	0.0883291732582717	0	0	17.483333333333334	49.55372022159112	EP300
Apoptosis Block in Melanoma Cell	1/39	0.05875726186108227	0.0883291732582717	0	0	17.483333333333334	49.55372022159112	JAK2
CD38/CD19 -> JUN/FOS/NF-kB Signaling in B-cell Proliferation	1/39	0.05875726186108227	0.0883291732582717	0	0	17.483333333333334	49.55372022159112	PRKCB
Hair Follicle Keratinocyte Apoptosis	1/39	0.05875726186108227	0.0883291732582717	0	0	17.483333333333334	49.55372022159112	JAK2
Proteins Involved in Noise-Induced Hearing Loss	1/40	0.06021903535976484	0.08919976461890698	0	0	17.034188034188034	47.86209557175929	JAK2
SIRT1 Signaling in Aging	1/40	0.06021903535976484	0.08919976461890698	0	0	17.034188034188034	47.86209557175929	EP300
Telomer Attrition Triggers Genomic Instability	1/40	0.06021903535976484	0.08919976461890698	0	0	17.034188034188034	47.86209557175929	EP300
G0/G1 Phase Transition	1/40	0.06021903535976484	0.08919976461890698	0	0	17.034188034188034	47.86209557175929	JAK2
Proteins with Altered Expression in Endometriosis	1/41	0.0616786118590254	0.08919976461890698	0	0	16.6075	46.2654733568564	CDH1
Th17-Cell Activation in Crohn's Disease	1/41	0.0616786118590254	0.08919976461890698	0	0	16.6075	46.2654733568564	JAK2
Golgi to Endosome Transport	1/41	0.0616786118590254	0.08919976461890698	0	0	16.6075	46.2654733568564	PRKCD
AMPK Signaling	1/41	0.0616786118590254	0.08919976461890698	0	0	16.6075	46.2654733568564	HDAC5
Club-Cell Role in Asthma	1/41	0.0616786118590254	0.08919976461890698	0	0	16.6075	46.2654733568564	JAK2
T-Cell Receptor -> NF-kB Signaling	1/41	0.0616786118590254	0.08919976461890698	0	0	16.6075	46.2654733568564	PRKCB
Insulin Resistance in Myocytes Induced by Obesity	1/41	0.0616786118590254	0.08919976461890698	0	0	16.6075	46.2654733568564	JAK2
Mesangial Cell Dysfunction in Glomerulonephritis	1/41	0.0616786118590254	0.08919976461890698	0	0	16.6075	46.2654733568564	PRKCD
Serotonin Receptors Signaling	1/42	0.06313599453486288	0.08956141061113362	0	0	16.201626016260164	44.75641243015854	JAK2
T-Cell Central Tolerance	1/42	0.06313599453486288	0.08956141061113362	0	0	16.201626016260164	44.75641243015854	EP300
Clozapine Induced Granulocytopenia	1/42	0.06313599453486288	0.08956141061113362	0	0	16.201626016260164	44.75641243015854	JAK2
Hippo/YAP1 Signaling Deregulation in Cancer	1/42	0.06313599453486288	0.08956141061113362	0	0	16.201626016260164	44.75641243015854	STK4
Skeletal Muscle Wasting in Cancer Cachexia	1/42	0.06313599453486288	0.08956141061113362	0	0	16.201626016260164	44.75641243015854	JAK2
Cowden Syndrome	1/42	0.06313599453486288	0.08956141061113362	0	0	16.201626016260164	44.75641243015854	JAK2
WNT Signaling in Cystic Kidney Disease	1/43	0.06459118658971515	0.08956141061113362	0	0	15.815079365079365	43.328214060740166	ARRB1
WNT in Epithelial to Mesenchymal Transition in Cancer	1/43	0.06459118658971515	0.08956141061113362	0	0	15.815079365079365	43.328214060740166	CDH1
Ependymoma	1/43	0.06459118658971515	0.08956141061113362	0	0	15.815079365079365	43.328214060740166	EP300
Graves Ophthalmopathy	1/43	0.06459118658971515	0.08956141061113362	0	0	15.815079365079365	43.328214060740166	JAK2
IGF1R/AKT Signaling in Breast Cancer	1/43	0.06459118658971515	0.08956141061113362	0	0	15.815079365079365	43.328214060740166	JAK2
MicroRNAs Role in Melanoma	1/43	0.06459118658971515	0.08956141061113362	0	0	15.815079365079365	43.328214060740166	CDH1
T-Cells Differentiation Block in Psoriasis	1/44	0.06604419119464339	0.08956141061113362	0	0	15.446511627906977	41.97483258957492	JAK2
CDH1 Down regulation Promotes Cancer Cell Migration and Metastases	1/44	0.06604419119464339	0.08956141061113362	0	0	15.446511627906977	41.97483258957492	CDH1
Adipokines Production by Adipocyte Impaired in Obesity	1/44	0.06604419119464339	0.08956141061113362	0	0	15.446511627906977	41.97483258957492	JAK2
Adiponectin Synthesis Declines in Insulin Resistance	1/44	0.06604419119464339	0.08956141061113362	0	0	15.446511627906977	41.97483258957492	JAK2
Alveolar Macrophage Negative Regulation Declined in COPD	1/44	0.06604419119464339	0.08956141061113362	0	0	15.446511627906977	41.97483258957492	JAK2
Arterial Hypertension	1/44	0.06604419119464339	0.08956141061113362	0	0	15.446511627906977	41.97483258957492	EP300
beta-Cell Mass Regulation	1/44	0.06604419119464339	0.08956141061113362	0	0	15.446511627906977	41.97483258957492	JAK2
FOXO1 Signaling	1/44	0.06604419119464339	0.08956141061113362	0	0	15.446511627906977	41.97483258957492	JAK2
CagA Phosphorylation Independent Signaling	1/44	0.06604419119464339	0.08956141061113362	0	0	15.446511627906977	41.97483258957492	CDH1
Splenic Marginal Zone Lymphoma	1/45	0.06749501152086855	0.09125804812141103	0	0	15.094696969696969	40.69079857995566	PRKCB
Adipokines Production by Adipocyte	1/46	0.06894365075528797	0.09185786704130204	0	0	14.75851851851852	39.471152501452366	JAK2
Proteins with Altered Expression in Melanoma	1/46	0.06894365075528797	0.09185786704130204	0	0	14.75851851851852	39.471152501452366	CDH1
Toll-like Receptors in beta-Cell	1/46	0.06894365075528797	0.09185786704130204	0	0	14.75851851851852	39.471152501452366	JAK2
MERTK Signaling	1/46	0.06894365075528797	0.09185786704130204	0	0	14.75851851851852	39.471152501452366	PRKCB
Ras-GAP Regulation Signaling	1/46	0.06894365075528797	0.09185786704130204	0	0	14.75851851851852	39.471152501452366	JAK2
TGFBR Signaling in Pancreatic Neoplasms	1/47	0.07039011205855722	0.09190937488788756	0	0	14.43695652173913	38.311387316676615	EP300
Tubular Cell Dysfunction in Progressive Diabetic Nephropathy	1/47	0.07039011205855722	0.09190937488788756	0	0	14.43695652173913	38.311387316676615	JAK2
Genes with Mutations in Cancer-Associated Evading of Growth Suppressors	1/47	0.07039011205855722	0.09190937488788756	0	0	14.43695652173913	38.311387316676615	CDH1
IL6/IGF1/VEGFA Signaling in Multiple Myeloma	1/47	0.07039011205855722	0.09190937488788756	0	0	14.43695652173913	38.311387316676615	JAK2
Keratinocyte Activation in Psoriatic Arthritis	1/47	0.07039011205855722	0.09190937488788756	0	0	14.43695652173913	38.311387316676615	JAK2
Mucin Production in Goblet Airway Epithelial Cells	1/47	0.07039011205855722	0.09190937488788756	0	0	14.43695652173913	38.311387316676615	JAK2
Osteoclast Activation in Psoriatic Arthritis	1/47	0.07039011205855722	0.09190937488788756	0	0	14.43695652173913	38.311387316676615	JAK2
T-Cell Cytotoxic Mediated Cell Death	1/48	0.07183439859286861	0.09273536767497445	0	0	14.129078014184397	37.20739858844958	JAK2
EGFR/ERBB3 -> MEF/MYOD/NFATC/MYOG Signaling	1/48	0.07183439859286861	0.09273536767497445	0	0	14.129078014184397	37.20739858844958	EP300
Bone Loss in Osteoporosis	1/48	0.07183439859286861	0.09273536767497445	0	0	14.129078014184397	37.20739858844958	JAK2
Diffuse Large-B-Cell Lymphoma ABC Subtype	1/48	0.07183439859286861	0.09273536767497445	0	0	14.129078014184397	37.20739858844958	JAK2
Mast-Cell Activation without Degranulation	1/49	0.0732765135248936	0.09354013039350943	0	0	13.834027777777777	36.15544100556018	JAK2
Goblet-Cell Related Mucus Secretion in Asthma	1/49	0.0732765135248936	0.09354013039350943	0	0	13.834027777777777	36.15544100556018	JAK2
mTOR/NF-kB/BCR Signaling Disregulation in Mantle Cell Lymphoma	1/49	0.0732765135248936	0.09354013039350943	0	0	13.834027777777777	36.15544100556018	PRKCB
Polycystins Mutation Effects in Cystic Kidney Disease	1/49	0.0732765135248936	0.09354013039350943	0	0	13.834027777777777	36.15544100556018	JAK2
Proteins Involved in Glioma	2/290	0.07400310054813748	0.09380610500329897	0	0	4.712883141762452	12.270690120561428	VDR;PRKCB
Proteins Involved in Endometrial Cancer	1/50	0.07471646000262763	0.09380610500329897	0	0	13.551020408163266	35.15209038871121	CDH1
Proteins Involved in Vitiligo	1/50	0.07471646000262763	0.09380610500329897	0	0	13.551020408163266	35.15209038871121	VDR
Smooth Muscle Cell Dysfunction in Arterial Hypertension	1/50	0.07471646000262763	0.09380610500329897	0	0	13.551020408163266	35.15209038871121	PRKCD
Th17-Cell Function in Systemic Lupus Erythematosus	1/50	0.07471646000262763	0.09380610500329897	0	0	13.551020408163266	35.15209038871121	JAK2
Eosinophil Survival in Asthma	1/50	0.07471646000262763	0.09380610500329897	0	0	13.551020408163266	35.15209038871121	JAK2
Macrophage M1 Lineage	1/51	0.0761542411780185	0.09431568622860285	0	0	13.279333333333334	34.194210378566844	JAK2
Scavenger Receptor OLR1 in Inflammation Related Endothelial Dysfunction	1/51	0.0761542411780185	0.09431568622860285	0	0	13.279333333333334	34.194210378566844	PRKCB
Vascular Endothelial Cell Activation by Growth Factors	1/51	0.0761542411780185	0.09431568622860285	0	0	13.279333333333334	34.194210378566844	JAK2
ROS in Angiotensin Mediated Cardiovascular Remodeling and Hypertrophy	1/51	0.0761542411780185	0.09431568622860285	0	0	13.279333333333334	34.194210378566844	JAK2
Hashimoto's Thyroiditis	1/51	0.0761542411780185	0.09431568622860285	0	0	13.279333333333334	34.194210378566844	JAK2
Myeloid Derived Suppressor Cells in Cancer Immune Escape	1/52	0.0775898601982381	0.09480900029570806	0	0	13.018300653594771	33.27892316228608	JAK2
VEGF Independent Angiogenesis in Cancer	1/52	0.0775898601982381	0.09480900029570806	0	0	13.018300653594771	33.27892316228608	JAK2
EGFR Signaling	1/52	0.0775898601982381	0.09480900029570806	0	0	13.018300653594771	33.27892316228608	JAK2
NF-kB Canonical Signaling	1/52	0.0775898601982381	0.09480900029570806	0	0	13.018300653594771	33.27892316228608	PRKCB
Peutz-Jeghers Syndrome	1/52	0.0775898601982381	0.09480900029570806	0	0	13.018300653594771	33.27892316228608	EP300
Proteins Involved in Multiple Sclerosis	1/54	0.08045462435891494	0.09701256815837501	0	0	12.525786163522012	31.56575680442027	VDR
Airway Smooth Muscle Cell High Rate Proliferation	1/54	0.08045462435891494	0.09701256815837501	0	0	12.525786163522012	31.56575680442027	JAK2
ERBB/VEGFR/Akt Signaling in Breast Cancer	1/54	0.08045462435891494	0.09701256815837501	0	0	12.525786163522012	31.56575680442027	JAK2
Mast-Cells Activation in Atopic Dermatitis	1/54	0.08045462435891494	0.09701256815837501	0	0	12.525786163522012	31.56575680442027	PRKCB
Mucin Hyperproduction in Goblet and Mucous Cells	1/54	0.08045462435891494	0.09701256815837501	0	0	12.525786163522012	31.56575680442027	JAK2
Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway	1/55	0.08188377576047076	0.09770466193873405	0	0	12.29320987654321	30.763197218330607	JAK2
beta-Cell Destruction in Diabetes Mellitus Type 1	1/55	0.08188377576047076	0.09770466193873405	0	0	12.29320987654321	30.763197218330607	JAK2
Dendritic Cell Activation in Systemic Lupus Erythematosis	1/55	0.08188377576047076	0.09770466193873405	0	0	12.29320987654321	30.763197218330607	JAK2
Endothelial Cell Dysfunction in Glomerulonephritis	1/55	0.08188377576047076	0.09770466193873405	0	0	12.29320987654321	30.763197218330607	JAK2
Proteins Involved in B-Cell Chronic Lymphocytic Leukemia	1/56	0.0833107775481581	0.09863478067230118	0	0	12.069090909090908	29.993831432939842	PRKCD
T-Cell Independent B-Cell Activation	1/56	0.0833107775481581	0.09863478067230118	0	0	12.069090909090908	29.993831432939842	PRKCB
Hyaluronic Acid, CD44 and HMMR in Cancer Cell Invasion and Survival	1/56	0.0833107775481581	0.09863478067230118	0	0	12.069090909090908	29.993831432939842	JAK2
Synovial Fibroblast Proliferation in Rheumatoid Arthritis	1/57	0.08473563284794243	0.0990388343005363	0	0	11.852976190476191	29.2557418815663	JAK2
Vascular Endothelial Cell Activation by Blood Coagulation Factors	1/57	0.08473563284794243	0.0990388343005363	0	0	11.852976190476191	29.2557418815663	JAK2
beta-Cell Destruction through Cytokines in Diabetes Mellitus	1/57	0.08473563284794243	0.0990388343005363	0	0	11.852976190476191	29.2557418815663	JAK2
MITF as a Regulator of Melanoma Cell Development	1/57	0.08473563284794243	0.0990388343005363	0	0	11.852976190476191	29.2557418815663	CDH1
Osteoclast Activation in Rheumatoid Arthritis	1/57	0.08473563284794243	0.0990388343005363	0	0	11.852976190476191	29.2557418815663	JAK2
Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma	1/58	0.08615834477824497	0.10018922026376068	0	0	11.644444444444444	28.547152703267713	PRKCB
Osteoclast Activation in Gout	1/58	0.08615834477824497	0.10018922026376068	0	0	11.644444444444444	28.547152703267713	JAK2
Proteins Involved in Psoriasis	1/59	0.08757891647548653	0.10081502475893539	0	0	11.443103448275862	27.86641704377016	VDR
Proteins Involved in Psoriatic Arthritis	1/59	0.08757891647548653	0.10081502475893539	0	0	11.443103448275862	27.86641704377016	PRKCD
Positive Acute Phase Proteins Synthesis	1/59	0.08757891647548653	0.10081502475893539	0	0	11.443103448275862	27.86641704377016	JAK2
Bone Remodeling in Hyperthyroidism	1/59	0.08757891647548653	0.10081502475893539	0	0	11.443103448275862	27.86641704377016	VDR
Proteins Involved in Female Infertility	1/60	0.0889973510131811	0.10219042566086373	0	0	11.248587570621469	27.21200570122755	CDH1
Proteins Involved in Periodontitis	1/61	0.09041365153331592	0.10355648809705609	0	0	11.060555555555556	26.582496915567003	VDR
CD8+ T-Cell Activation	1/62	0.09182782112653406	0.1046516564958256	0	0	10.878688524590164	25.97656722459872	JAK2
VEGFA Dependent Angiogenesis in Cancer	1/62	0.09182782112653406	0.1046516564958256	0	0	10.878688524590164	25.97656722459872	JAK2
T-Cell Dependent B-Cell Activation	1/63	0.09323986288089035	0.10469439149033634	0	0	10.702688172043011	25.39298321204175	PRKCB
Th17-Cell Differentiation	1/63	0.09323986288089035	0.10469439149033634	0	0	10.702688172043011	25.39298321204175	JAK2
EGFR Transactivation in Cancer and Non-Cancer Cells	1/63	0.09323986288089035	0.10469439149033634	0	0	10.702688172043011	25.39298321204175	ZBTB16
IDO1 in Cancer Immune Escape	1/63	0.09323986288089035	0.10469439149033634	0	0	10.702688172043011	25.39298321204175	JAK2
Basophil Activation in Asthma	1/63	0.09323986288089035	0.10469439149033634	0	0	10.702688172043011	25.39298321204175	JAK2
Dendritic Cell Dysfunction in Psoriatic Arthritis	1/63	0.09323986288089035	0.10469439149033634	0	0	10.702688172043011	25.39298321204175	JAK2
Th1-Cell Differentiation	1/64	0.09464977990360633	0.10601703288222572	0	0	10.532275132275132	24.830594069685887	JAK2
Natural Killer Cell Activation	1/65	0.09605757528589014	0.10629131212022226	0	0	10.3671875	24.288324885251964	JAK2
Th17-Cell Differentiation in Asthma	1/65	0.09605757528589014	0.10629131212022226	0	0	10.3671875	24.288324885251964	JAK2
Cardiomyocyte Hypertrophy	1/65	0.09605757528589014	0.10629131212022226	0	0	10.3671875	24.288324885251964	JAK2
HPV Infection and Cancer	1/65	0.09605757528589014	0.10629131212022226	0	0	10.3671875	24.288324885251964	CDH1
Natural Killer T-Cell Roles in Diabetes Mellitus Type 1	1/65	0.09605757528589014	0.10629131212022226	0	0	10.3671875	24.288324885251964	ZBTB16
Proteins Involved in Inflammatory Bowel Diseases	1/66	0.09746325210209762	0.10681224510949308	0	0	10.207179487179488	23.765170565615563	VDR
Th17-Cell and Th1 Immune Responsein Psoriatic Arthritis	1/66	0.09746325210209762	0.10681224510949308	0	0	10.207179487179488	23.765170565615563	JAK2
Toll-like Receptor Independent Sterile Inflammation	1/66	0.09746325210209762	0.10681224510949308	0	0	10.207179487179488	23.765170565615563	PRKCD
Vascular Endothelial Cell Activation by Cytokines	1/66	0.09746325210209762	0.10681224510949308	0	0	10.207179487179488	23.765170565615563	JAK2
CD16/CD14 Proinflammatory Monocyte Activation	1/67	0.09886681344336717	0.1078332547580401	0	0	10.052020202020202	23.26019032662989	JAK2
Skin Fibrosis	1/67	0.09886681344336717	0.1078332547580401	0	0	10.052020202020202	23.26019032662989	JAK2
Cholesteatoma	1/70	0.10306483535857697	0.11161286672717931	0	0	9.61352657004831	21.8457491225909	JAK2
Chronic Myeloid Leukemia	1/70	0.10306483535857697	0.11161286672717931	0	0	9.61352657004831	21.8457491225909	JAK2
Growth Factor Signaling in Pancreatic Neoplasms	1/70	0.10306483535857697	0.11161286672717931	0	0	9.61352657004831	21.8457491225909	JAK2
Cytokines Trigger Otitis Media	1/71	0.10445996552065845	0.11285627480600686	0	0	9.475714285714286	21.405177919492388	JAK2
Eosinophil Survival by Cytokine Signaling	1/72	0.1058529955609793	0.11355591307832756	0	0	9.341784037558686	20.978881609749415	JAK2
Th1-Cells Activation and Proliferation in Atherosclerosis	1/72	0.1058529955609793	0.11355591307832756	0	0	9.341784037558686	20.978881609749415	JAK2
Lymphocyte Mediated Myocardial Injury in Myocarditis	1/72	0.1058529955609793	0.11355591307832756	0	0	9.341784037558686	20.978881609749415	JAK2
TGFB Signaling activation by Blocking of Tumor Suppressors	1/73	0.10724392850313601	0.11477863073989031	0	0	9.211574074074074	20.566214716689423	EP300
B-Cell Acute Lymphoblastic Leukemia	1/74	0.10863276741747166	0.1159933988546368	0	0	9.084931506849315	20.166569167475306	JAK2
NFKB Canonical Signaling Activation in Cancer	1/75	0.1100195153566116	0.11720027626566784	0	0	8.961711711711711	19.77937166333769	PRKCB
Vitiligo	1/78	0.11416724371228316	0.1213358845965428	0	0	8.611255411255412	18.687206622741385	JAK2
Basophil Activation	1/79	0.1155456581169776	0.1222323281468953	0	0	8.500427350427351	18.344683169954745	JAK2
Th0-Cell Aberrant Activation in Systemic Lupus Erythematosus	1/79	0.1155456581169776	0.1222323281468953	0	0	8.500427350427351	18.344683169954745	PRKCD
TGFB Family in Epithelial to Mesenchymal Transition in Cancer	1/80	0.11692199671950551	0.12340266166469752	0	0	8.39240506329114	18.01218477461978	CDH1
Proteins Involved in Insulin Resistance	1/81	0.11829626253520985	0.12456541930550899	0	0	8.287083333333333	17.689302303265983	JAK2
Growth Factor Signaling in Hepatocellular Carcinoma	1/82	0.11966845858358988	0.12572065648896683	0	0	8.184362139917695	17.37564803201433	JAK2
Proteins Involved in Osteoarthritis	1/86	0.12513660526532908	0.1311638270785674	0	0	7.79764705882353	16.206234277302418	VDR
Hypertrophic Cardiomyopathy	1/89	0.1292161299361437	0.13512991162658508	0	0	7.530681818181818	15.409799629222077	JAK2
T-Cell Cytotoxic Response against Melanocytes in Vitiligo	1/90	0.13057187592621022	0.1362359527357947	0	0	7.4456928838951315	15.158175594574578	JAK2
CD4+T-Cell Response in Celiac Disease	1/91	0.1319255791544341	0.1373348284136136	0	0	7.362592592592593	14.91305874036	JAK2
Proteins Involved in Cataract	1/94	0.1359744617032879	0.1409077755065818	0	0	7.124014336917563	14.21446168945804	CDH1
Proteins Involved in Pancreatic Cancer	1/94	0.1359744617032879	0.1409077755065818	0	0	7.124014336917563	14.21446168945804	CDH1
Proteins Involved in Rheumatoid Arthritis	1/96	0.1386635571508699	0.1433693339772569	0	0	6.973333333333334	13.77724766471137	PADI4
Proteins Involved in Diabetes Mellitus Type 1	1/97	0.14000506588878114	0.14442960521709478	0	0	6.900347222222222	13.566611703053766	VDR
Proteins Involved in Huntington Disease	1/98	0.14134455256627768	0.14515609106244695	0	0	6.828865979381443	13.361050061201011	HDAC5
Proteins Involved in Parkinson's Disease	1/98	0.14134455256627768	0.14515609106244695	0	0	6.828865979381443	13.361050061201011	PRKCD
Proteins Involved in Polycystic Ovary Syndrome	1/99	0.14268202012005496	0.14620108339655855	0	0	6.758843537414966	13.16039270810627	VDR
Proteins Involved in Osteoporosis	1/100	0.14401747150131122	0.14723933887270518	0	0	6.69023569023569	12.964476920040203	VDR
Medulloblastoma	1/104	0.14933917399017552	0.1523392913247996	0	0	6.429126213592233	12.225209957636702	EP300
Proteins with Altered Expression in Cancer Metastases	1/106	0.15198800438142535	0.15469603118554873	0	0	6.306031746031746	11.880271712830174	CDH1
Hodgkin Lymphoma	1/110	0.15726174007999252	0.1597080338145702	0	0	6.073394495412844	11.234830711924577	JAK2
Genes with Mutations in Cancer-Associated Sustaining of Proliferative Signaling	1/112	0.15988669182841242	0.16201378750683917	0	0	5.963363363363364	10.932573768600097	JAK2
Receptors and Adaptor Proteins Activated in Cancer	1/125	0.1767570211186702	0.17871229790095639	0	0	5.334677419354839	9.244885281458137	JAK2
Proteins Involved in Pulmonary Hypertension	1/165	0.22663474904183437	0.22863593887884837	0	0	4.025406504065041	5.97537618056734	ATF7IP
Proteins Involved in Glioblastoma	1/178	0.2422058302138552	0.24380630926813177	0	0	3.727306967984934	5.28519968188763	CDH1
Proteins Involved in non-Alcoholic Fatty Liver Disease	1/186	0.251636767276824	0.2527428629571617	0	0	3.5646846846846847	4.918440107268859	PRKCD
Proteins Involved in Myocarditis	1/207	0.2758557529268061	0.2764606997534	0	0	3.19789644012945	4.118497862706142	KMT2A
Proteins Involved in Epilepsy	1/270	0.34404836687895	0.34404836687895	0	0	2.4411400247831474	2.604630569140999	VDR
